Simon Crabb

Has grant

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Genotype of Urothelial cancer: Stratified Treatment and Oncological outcomes (GUSTO): Phase II study

Open Date: 2021-12-01

Close Date: 2027-11-30

Grant: Close

A multicentre randomised controlled trial (RCT) of a self-help cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flush and night sweat (HFNS) symptoms in men with prostate cancer undergoing androgen deprivation therapy (ADT): MANaging symptoms during prostate CANcer treatment (MANCAN2)

Open Date: 2021-05-01

Close Date: 2024-04-30

Grant: Close

ELEKTRA: Intraoperative electron radiotherapy in rectal cancer

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

AURORA: Atezolizumab in patients with squamous cell carcinoma of the bladder and urinary tract – a single arm, open label, multicentre, phase II trial

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

CRAIN: A phase 1b clinical trial with dose escalation and dose expansion phases of ASTX660 in combination with standard radical radiotherapy in cervical cancer with chemoradiation

Open Date: 2020-01-01

Close Date: 2024-01-01

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Robert Jones

University of Glasgow

UNITED KINGDOM

View details

SARAH DANSON

University of Sheffield

UNITED KINGDOM

View details

Maria Teresa Borrello

Lecturer in Pharmaceutical sciences

University of Sunderland

UNITED KINGDOM

View details

Umberto Basso

Consultant Medical Oncologist, Full Time. Chief of Genito-Urinary Program

Istituto Oncologico Veneto IOV-IRCCS

ITALY

View details

Graham Packham

University of Southampton

UNITED KINGDOM

View details

A Ganesan

Professor

University of East Anglia

UNITED KINGDOM

View details

Samantha Hinsley

University of Glasgow

UNITED KINGDOM

View details

Malcolm West

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simon Crabb

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (13)

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study

The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology

Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective

Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland

Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma

Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia.

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

V-ATPase Inhibition Decreases Mutant Androgen Receptor Activity in Castrate-resistant Prostate Cancer

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens

Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial.

Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?

Collaborators (8)

Robert Jones

SARAH DANSON

Maria Teresa Borrello

Umberto Basso

Graham Packham

A Ganesan

Samantha Hinsley

Malcolm West

Make your next move.